Major pharma companies that manufacture generic drugs, Sun Pharmaceuticals, Jubilant Cadista and Lupin, are recalling their various drugs in the US market. There is a different way of recalling medicines. Given that America is the largest market for medicines.

According to the latest enforcement report by the USFDA, the US-based unit of Lupin is recalling 17,814 bottles of Cefprozil for Oral Suspension USP, a second-generation antibiotic used to treat infections of the ear, skin and other bacterial infections.

The company is recalling the affected lot for being “Superpotent”. The affected lot has been manufactured at Lupin’s Mandideep plant in Madhya Pradesh and distributed in the US by Baltimore-based Lupin Pharmaceuticals Inc. Lupin initiated the Class II voluntary recall across the US and Puerto Rico on March 26 this year.

Sun Pharma is recalling 13,834 bottles of diabetes drug Riomet (metformin hydrochloride oral solution) in the US due to “Microbial Contamination of Non-Sterile Product”. The affected lot has been distributed in the US by New Jersey-based Sun Pharmaceutical Industries Inc. The company initiated Class II nationwide recall on March 31 this year.

US-based Jubilant Cadista Pharmaceuticals is recalling 12,192 bottles of an antifungal medication Itraconazole Capsules due to “Failed Dissolution Specifications”. The company is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of the Noida-based Jubilant Life Sciences Company.

The affected lot has been produced by Jubilant Generics at its Roorkee-based plant in Uttarakhand and marketed in the US by Salisbury-based Jubilant Cadista Pharmaceuticals, Inc. Jubilant commenced Class II recall in the US on April 1, 2021.

HCL Technologies to move workloads from India to deal with Covid-19 surge

Pandemic fruit: Foreign portfolio investors draw out Rs 7622-Cr thus far in April

India's processed food product exports shimmer 26.51 pc during April-Feb FY 20-21